You are here

  • Home
  • Online First
  • Oral steroids for improved function but not pain in acute radiculopathy due to disc herniation

Article Text

Article menu

other Versions

Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Oral steroids for improved function but not pain in acute radiculopathy due to disc herniation
  1. Steven P Cohen
  1. Johns Hopkins Medical Institutions & Walter Reed National Military Medical Center, Baltimore, Maryland, USA
  1. Correspondence to: Dr Steven P Cohen, Johns Hopkins Medical Institutions, 550 North Broadway, Suite 301, Baltimore, MD 21205, USA; scohen40{at}jhmi.edu

https://doi.org/10.1136/ebmed-2015-110240

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Goldberg H, Firtch W, Tyburski M, et al. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomised clinical trial. JAMA 2015;313:1915–23.OpenUrlCrossRefPubMed

    Context

    The toll low back pain (LBP) exerts on society is enormous. Approximately 40% of cases of chronic LBP are primarily neuropathic in nature,1 which may make them responsive to corticosteroids. A randomised trial performed in 208 patients with acute radiculopathy found that 30% of those who received piroxicam or placebo continued to experience symptoms at 3 months, with few people reporting resolution afterwards.2 These results are consistent with other studies suggesting that radicular pain that persists for longer than 3 months after injury is likely to become chronic. For systemic steroids, most but not all studies have failed to demonstrate significant benefit.3

    Methods

    The authors performed a randomised, double-blind, placebo-controlled …

    View Full Text

    Footnotes

    • Competing interests SPC served as a consultant for Semnur Pharmaceuticals, which is trying to develop an FDA-approved steroid for epidural injection.

    • Provenance and peer review Commissioned; internally peer reviewed.